Redox remodeling as an immunoregulatory strategy

Biochemistry

Volumn 49, Issue 6, 2010, Pages 1059-1066

  Yan, Zhonghua ^a   Banerjee, Ruma ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNE SYSTEMS; ANTIGEN PRESENTING CELLS; ANTIOXIDANT RESPONSE; AUTOIMMUNE DISEASE; DENDRITIC CELLS; EXTRACELLULAR; GLUTATHIONES; IMMUNE RESPONSE; MICROENVIRONMENTS; NATURALLY OCCURRING; REDOX POTENTIALS; REDOX REGULATION; T CELL ACTIVATION; T CELL PROLIFERATION; T CELLS;

CELL PROLIFERATION; ENZYME ACTIVITY; IMMUNOLOGY; LAWS AND LEGISLATION; VIRUSES;

DENDRIMERS;

GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIGEN PRESENTING CELL; ANTIOXIDANT ACTIVITY; AUTOIMMUNITY; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; DENDRITIC CELLS; EXTRACELLULAR FLUID; G0 PHASE; LYMPHOCYTE ACTIVATION; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 76749096867     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi902022n     Document Type: Review

References (79)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
2. Sakaguchi, S., Yamaguchi, T., Nomura, T., and Ono, M. (2008) Regulatory T cells and immune tolerance. Cell 133, 775-787.
3. Vignali, D. A., Collison, L. W., and Workman, C. J. (2008) How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532.
4. Tseng, S. Y., and Dustin, M. L. (2002) T-cell activation: A multidimensional signaling network. Curr. Opin. Cell Biol. 14, 575-580.
5. Abbas, A. K. (2003) The control of T cell activation vs. tolerance. Autoimmun. Rev. 2, 115-118.
6. Banchereau, J., and Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
7. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., and Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
8. Lanzavecchia, A., and Sallusto, F. (2001) Regulation of T cell immunity by dendritic cells. Cell 106, 263-266.
9. Angelini, G., Gardella, S., Ardy, M., Ciriolo, M. R., Filomeni, G., Di Trapani, G., Clarke, F., Sitia, R., and Rubartelli, A. (2002) Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. U.S.A. 99, 1491-1496.
10. Yan, Z., Garg, S. K., Kipnis, J., and Banerjee, R. (2009) Extracellular redox modulation by regulatory T cells. Nat. Chem. Biol. 5, 721-723.
11. Sido, B., Braunstein, J., Breitkreutz, R., Herfarth, C., and Meuer, S. C. (2000) Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J. Exp. Med. 192, 907-912.
12. Sido, B., Lasitschka, F., Giese, T., Gassler, N., Funke, B., Schroder-Braunstein, J., Brunnemer, U., Meuer, S. C., and Autschbach, F. (2008) A prominent role for mucosal cystine/cysteine metabolism in intestinal immunoregulation. Gastroenterology 134, 179-191.
13. Hori, S., Nomura, T., and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
14. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., and Ochs, H. D. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21.
15. Chambers, C. A., Kuhns, M. S., Egen, J. G., and Allison, J. P. (2001) CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19, 565-594.
16. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., and Sakaguchi, S. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275.
17. Moriarty-Craige, S. E., and Jones, D. P. (2004) Extracellular thiols and thiol/disulfide redox in metabolism. Annu. Rev. Nutr. 24, 481-509.
18. Kemp, M., Go, Y. M., and Jones, D. P. (2008) Nonequilibrium thermodynamics of thiol/disulfide redox systems: A perspective on redox systems biology. Free Radical Biol. Med. 44, 921-937.
19. Meister, A., and Anderson, M. E. (1983) Glutathione. Annu. Rev. Biochem. 52, 711-760.
20. Eck, H. P., Gmunder, H., Hartmann, M., Petzoldt, D., Daniel, V., and Droge, W. (1989) Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol. Chem. Hoppe-Seyler 370, 101-108.
21. Karp, D. R., Shimooku, K., and Lipsky, P. E. (2001) Expression of γ-glutamyl transpeptidase protects ramos B cells from oxidationinduced cell death. J. Biol. Chem. 276, 3798-3804.
22. Ghezzi, P., Bonetto, V., and Fratelli, M. (2005) Thiol-disulfide balance: From the concept of oxidative stress to that of redox regulation. Antioxid. Redox Signaling 7, 964-972.
23. Jones, D. P. (2008) Radical-free biology of oxidative stress. Am. J. Physiol. 295, C849-C868.
24. Jordan, P. A., and Gibbins, J. M. (2006) Extracellular disulfide exchange and the regulation of cellular function. Antioxid. Redox Signaling 8, 312-324.
25. Hynes, R. O., and Destree, A. (1977) Extensive disulfide bonding at the mammalian cell surface. Proc. Natl. Acad. Sci. U.S.A. 74, 2855-2859.
26. Ali, I. U., and Hynes, R. O. (1978) Role of disulfide bonds in the attachment and function of large, external, transformation-sensitive glycoprotein at the cell surface. Biochim. Biophys. Acta 510, 140-150.
27. Lawrence, D. A., Song, R., and Weber, P. (1996) Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation. J. Leukocyte Biol. 60, 611-618.
28. Matthias, L. J., Yam, P. T., Jiang, X. M., Vandegraaff, N., Li, P., Poumbourios, P., Donoghue, N., and Hogg, P. J. (2002) Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat. Immunol. 3, 727-732.
29. Castellani, P., Angelini, G., Delfino, L., Matucci, A., and Rubartelli, A. (2008) The thiol redox state of lymphoid organs is modified by immunization: Role of different immune cell populations. Eur. J. Immunol. 38, 2419-2425.
30. Gelderman, K. A., Hultqvist, M., Holmberg, J., Olofsson, P., and Holmdahl, R. (2006) T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc. Natl. Acad. Sci. U.S.A. 103, 12831-12836.
31. Droge, W., Eck, H. P., Gmunder, H., and Mihm, S. (1991) Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivatives. Am. J. Med. 91, 140S-144S.
32. Ishii, T., Sugita, Y., and Bannai, S. (1987) Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J. Cell. Physiol. 133, 330-336.
33. Nakamura, H., Masutani, H., and Yodoi, J. (2006) Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer. Semin. Cancer Biol. 16, 444-451.
34. Schwertassek, U., Balmer, Y., Gutscher, M., Weingarten, L., Preuss, M., Engelhard, J., Winkler, M., and Dick, T. P. (2007) Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1. EMBO J. 26, 3086-3097.
35. Arner, E. S., and Holmgren, A. (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109.
36. Pani, G., Colavitti, R., Borrello, S., and Galeotti, T. (2000) Redox regulation of lymphocyte signaling. IUBMB Life 49, 381-389.
37. Los, M., Schenk, H., Hexel, K., Baeuerle, P. A., Droge, W., and Schulze-Osthoff, K. (1995) IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14, 3731-3740.
38. Thoren, F. B., Betten, A., Romero, A. I., and Hellstrand, K. (2007) Cutting edge: Antioxidative properties of myeloid dendritic cells: Protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis. J. Immunol. 179, 21-25.
39. Secrist, J. P., Burns, L. A., Karnitz, L., Koretzky, G. A., and Abraham, R. T. (1993) Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 268, 5886-5893.
40. Yang, H., Magilnick, N., Lee, C., Kalmaz, D., Ou, X., Chan, J. Y., and Lu, S. C. (2005) Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-κB and AP-1. Mol. Cell. Biol. 25, 5933-5946.
41. Suthanthiran, M., Anderson, M. E., Sharma, V. K., and Meister, A. (1990) Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. U.S.A. 87, 3343-3347.
42. Messina, J. P., and Lawrence, D. A. (1989) Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J. Immunol. 143, 1974-1981.
43. Thelander, L., and Reichard, P. (1979) Reduction of ribonucleotides. Annu. Rev. Biochem. 48, 133-158.
44. Borras, C., Esteve, J. M., Vina, J. R., Sastre, J., Vina, J., and Pallardo, F. V. (2004) Glutathione regulates telomerase activity in 3T3 fibroblasts. J. Biol. Chem. 279, 34332-34335.
45. Schulze-Osthoff, K., Los, M., and Baeuerle, P. A. (1995) Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem. Pharmacol. 50, 735-741.
46. Markovic, J., Borras, C., Ortega, A., Sastre, J., Vina, J., and Pallardo, F. V. (2007) Glutathione is recruited into the nucleus in early phases of cell proliferation. J. Biol. Chem. 282, 20416-20424.
47. Menon, S. G., and Goswami, P. C. (2007)Aredox cycle within the cell cycle: Ring in the old with the new. Oncogene 26, 1101-1109.
48. Voehringer, D.W., McConkey, D. J., McDonnell, T. J.,Brisbay, S., and Meyn, R. E. (1998) Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. U.S.A. 95, 2956-2960.
49. Staal, F. J., Anderson, M. T., Staal, G. E., Herzenberg, L. A., and Gitler, C. (1994) Redox regulation of signal transduction: Tyrosine phosphorylation and calcium influx. Proc. Natl. Acad. Sci. U.S.A. 91, 3619-3622.
50. Gringhuis, S. I., Papendrecht-van der Voort, E. A., Leow, A., Nivine Levarht, E. W., Breedveld, F. C., and Verweij, C. L. (2002) Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol. Cell. Biol. 22, 400-411.
51. Hasan, A. A., Ghaemmaghami, A. M., Fairclough, L., Robins, A., Sewell, H. F., and Shakib, F. (2009) Allergen-driven suppression of thiol production by human dendritic cells and the effect of thiols on T cell function. Immunobiology 214, 2-16.
52. Peterson, J. D., Herzenberg, L. A., Vasquez, K., and Waltenbaugh, C. (1998) Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 3071-3076.
53. Fehervari, Z., and Sakaguchi, S. (2006) Peacekeepers of the immune system. Sci. Am. 295, 56-63.
54. Sakaguchi, S. (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
55. Sakaguchi, S., and Powrie, F. (2007) Emerging challenges in regulatory T cell function and biology. Science 317, 627-629.
56. Nakamura, K., Kitani, A., and Strober, W. (2001) Cell contactdependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194, 629-644.
57. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., and Powrie, F. (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004.
58. Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., and Vignali, D. A. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569.
59. Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S., and Noelle, R. J. (2005) Cutting edge: Contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786.
60. Cao, X., Cai, S. F., Fehniger, T. A., Song, J., Collins, L. I., Piwnica-Worms, D. R., and Ley, T. J. (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635-646.
61. Bopp, T., Becker, C., Klein, M., Klein-Hessling, S., Palmetshofer, A., Serfling, E., Heib, V., Becker, M., Kubach, J., Schmitt, S., Stoll, S., Schild, H., Staege, M. S., Stassen, M., Jonuleit, H., and Schmitt, E. (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303-1310.
62. Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J., and Mosmann, T. R. (2006) T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J. Immunol. 177, 6780-6786.
63. Tadokoro, C. E., Shakhar, G., Shen, S., Ding, Y., Lino, A. C., Maraver, A., Lafaille, J. J., and Dustin, M. L. (2006) Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203, 505-511.
64. Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M. L., and Puccetti, P. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206-1212.
65. Haddad, J. J., and Fahlman, C. S. (2002) Redox- and oxidantmediated regulation of interleukin-10: An anti-inflammatory, antioxidant cytokine? Biochem. Biophys. Res. Commun. 297, 163-176.
66. Barcellos-Hoff, M. H., and Dix, T. A. (1996) Redox-mediated activation of latent transforming growth factor-?1. Mol. Endocrinol. 10, 1077-1083.
67. Blakytny, R., Erkell, L. J., and Brunner, G. (2006) Inactivation of active and latent transforming growth factor β by free thiols: Potential redox regulation of biological action. Int. J. Biochem. Cell Biol. 38, 1363-1373.
68. Fan, Z., Beresford, P. J., Zhang, D., Xu, Z., Novina, C. D., Yoshida, A., Pommier, Y., and Lieberman, J. (2003) Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat. Immunol. 4, 145-153.
69. Carta, S., Castellani, P., Delfino, L., Tassi, S., Vene, R., and Rubartelli, A. (2009)DAMPsand inflammatory processes: The role of redox in the different outcomes. J. Leukocyte Biol. 86, 549-555.
70. Matsue, H., Edelbaum, D., Shalhevet, D., Mizumoto, N., Yang, C., Mummert, M. E., Oeda, J., Masayasu, H., and Takashima, A. (2003) Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 171, 3010-3018.
71. Masciarelli, S., and Sitia, R. (2008) Building and operating an antibody factory: Redox control during B to plasma cell terminal differentiation. Biochim. Biophys. Acta 1783, 578-588.
72. Tse, H. M., Milton, M. J., Schreiner, S., Profozich, J. L., Trucco, M., and Piganelli, J. D. (2007) Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness. J. Immunol. 178, 908-917.
73. Tse, H. M., Milton, M. J., and Piganelli, J. D. (2004) Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: implication for their use in targeting oxidation-reduction reactions in innate immunity. Free Radical Biol. Med. 36, 233-247.
74. Sklavos, M. M., Tse, H. M., and Piganelli, J. D. (2008) Redox modulation inhibits CD8 T cell effector function. Free Radical Biol. Med. 45, 1477-1486.
75. Gout, P. W., Simms, C. R., and Robertson, M. C. (2003) In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine. Anticancer Drugs 14, 21-29.
76. Banjac, A., Perisic, T., Sato, H., Seiler, A., Bannai, S., Weiss, N., Kolle, P., Tschoep, K., Issels, R. D., Daniel, P. T., Conrad, M., and Bornkamm, G. W. (2008) The cystine/cysteine cycle: A redox cycle regulating susceptibility versus resistance to cell death. Oncogene 27, 1618-1628.
77. Herzenberg, L. A., De Rosa, S. C., Dubs, J. G., Roederer, M., Anderson, M. T., Ela, S. W., and Deresinski, S. C. (1997) Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. U.S.A. 94, 1967-1972.
78. Edinger, A. L., and Thompson, C. B. (2002) Antigen-presenting cells controlTcell proliferation by regulating amino acid availability. Proc. Natl. Acad. Sci. U.S.A. 99, 1107-1109.
79. Becker, C., Stoll, S., Bopp, T., Schmitt, E., and Jonuleit, H. (2006) Regulatory T cells: Present facts and future hopes. Med. Microbiol. Immunol. 195, 113-124.